Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 (abstract O33). Estimated Number of Menstrual-Related Migraine Headache Days

From: 12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches

Period

Treatment

N

Estimated Number of MRMHDs per 30 day Period (SE)

95% CI

Rate Ratio per 30 day period

95% CI

P-value

ITT patients with baseline number of MRMHDs >0 for Episodic Migraine

 Average of Month 1 to 6

PBO

321

1.58 (0.13)

1.34, 1.86

   

120mg

170

1.16 (0.12)

0.96, 1.41

0.74

0.64, 0.85

<0.001

240mg

159

1.12 (0.12)

0.90, 1.38

0.71

0.60, 0.83

<0.001

ITT patients with baseline number of MRMHDs >0 for Chronic Migraine

 Average of Month 1 to 3

PBO

198

3.52 (0.18)

3.18, 3.90

   

120mg

112

2.58 (0.21)

2.58, 3.40

0.84

0.73, 0.97

0.015

240mg

97

3.01 (0.20)

2.64, 3.42

0.85

0.75, 0.98

0.021

  1. MRMHD Menstrual-Related Migraine Headache Days, CI confidence interval, ITT intent-to-treat, MM menstrual migraine, PBO placebo, SE standard error
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us